Description
Triple agonist of GLP-1, GIP, and glucagon receptors. Advanced research compound for metabolic studies. | 40mg total | 4 doses of 10mg | Alluvi Healthcare | Research purposes only. Not for human consumption.
Retatrutide (40mg)
£119.99
Triple agonist of GLP-1, GIP, and glucagon receptors. Advanced research compound for metabolic studies.
12 in stock
Additional information
| Alluvi Healthcare | 40mg |
|---|---|
| Injectable vial | research-only |
Related products
-
BPC-157 & TB-500 (40mg)
£99.99 -
GLOW GHK-Cu (10/10/50mg Blend)
£89.99 -
Retakilk® Retatrutide (40mg)
£129.99 -
Tesapro® Tesamorelin (30mg)
£119.99 -
Tirzepatide (40mg)
£89.99